Literature DB >> 23132676

High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.

Ruo-Yu Shi1, Xin-Rong Yang, Qiu-Jin Shen, Liu-Xiao Yang, Yang Xu, Shuang-Jian Qiu, Yun-Fan Sun, Xin Zhang, Zheng Wang, Kai Zhu, Wen-Xin Qin, Zhao-You Tang, Jia Fan, Jian Zhou.   

Abstract

BACKGROUND: Dickkopf-related protein 1 (DKK1) has been reported involved in metastasis and invasion in several tumors. This study sought to investigate the prognostic value of DKK1 in intrahepatic cholangiocarcinoma (ICC) and its role in promoting ICC metastasis.
METHODS: Tissue microarrays of 138 ICC patient samples were employed to detect DKK1, vascular endothelial growth factor C (VEGF-C), and matrix metalloproteinase 9 (MMP9) expression using immunohistochemistry. The prognostic significances were assessed by Kaplan-Meier survival estimates. DKK1 expression was measured in an ICC cell line (HCCC-9810) and ICC tissues by immunofluorescence assay, quantitative real-time polymerase chain reaction, and western blot. Serum levels of DKK1 from 37 ICC patients were tested by enzyme-linked immunosorbent assay. The role of DKK1 in proliferation, migration, invasion, and gene expression regulation was assessed by DKK1 depletion using small interfering RNA.
RESULTS: Multivariate analyses revealed that DKK1 was an unfavorable predictor for overall survival and time to recurrence. The prognostic significance was retained in ICC patients with low recurrence risk (P < .05). DKK1 expression was elevated in an ICC cell line, tumor samples, and patient sera. High levels of DKK1 in ICC tissues correlated with elevated MMP9, VEGF-C, and metastasis of hepatic hilar lymph nodes. DKK1 depletion caused a decrease in cell migration and invasiveness, and down-regulation of MMP9 and VEGF-C expression.
CONCLUSIONS: DKK1 is a novel prognostic biomarker for ICC, and it enhances tumor cell invasion and promotes lymph node metastasis of ICC through the induction of MMP9 and VEGF-C. DKK1 may be a potential therapeutic target for ICC.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23132676     DOI: 10.1002/cncr.27788

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 2.  Molecular diagnosis of intrahepatic cholangiocarcinoma.

Authors:  Hiroaki Haga; Tushar Patel
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-29       Impact factor: 7.027

Review 3.  Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

Authors:  Yuichi Sanada; Yujo Kawashita; Satomi Okada; Takashi Azuma; Shigetoshi Matsuo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  DKK1 inhibits proliferation and migration in human retinal pigment epithelial cells via the Wnt/β-catenin signaling pathway.

Authors:  Jinzi Zhou; Jian Jiang; Shuhong Wang; Xiaobo Xia
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

5.  WTAP regulates migration and invasion of cholangiocarcinoma cells.

Authors:  Hong-Jae Jo; Hye-Eun Shim; Myoung-Eun Han; Hyun-Jung Kim; Ki-Sun Kim; Sungmin Baek; Kyung-Un Choi; Gi-Yeong Hur; Sae-Ock Oh
Journal:  J Gastroenterol       Date:  2013-01-25       Impact factor: 7.527

6.  Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.

Authors:  Mei-Yuan Chen; Hao Zhang; Jian-Xin Jiang; Cheng-Yi Sun; Chao Yu; She Tian
Journal:  Tumour Biol       Date:  2016-08-19

Review 7.  The role of Dickkopf family in cancers: from Bench to Bedside.

Authors:  You-Cheng Shao; Yan Wei; Jin-Fang Liu; Xiao-Yan Xu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

8.  SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

Authors:  Yang Yu; Yan Chen; Jianxia Ma; Xiaofeng Yu; Guanzhen Yu; Zhaoshen Li
Journal:  Tumour Biol       Date:  2015-10-21

Review 9.  Dickkopf-1: A Promising Target for Cancer Immunotherapy.

Authors:  Hang Yin Chu; Zihao Chen; Luyao Wang; Zong-Kang Zhang; Xinhuan Tan; Shuangshuang Liu; Bao-Ting Zhang; Aiping Lu; Yuanyuan Yu; Ge Zhang
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

10.  Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.

Authors:  Yi Wang; Haitao Yu; Xiaozai Xie; Tuo Deng; Longyun Ye; Lijun Wu; Xiwei Ding; Zhen Yang; Qiandong Zhu; Junjian Li; Yihu Zheng; Zhengping Yu; Gang Chen
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.